In 2015, 10.4 billion new cases of tuberculosis (TB) were registered, 1.8 billion people died of TB, and multidrug-resistant (MDR) forms of TB developed in 480,000 patients 1 . According to the World Health Organization 2 , 46 per cent of all TB cases and 40 per cent of all deaths due to TB occur in five countries: Brazil, the Russian Federation, India, China and South Africa, comprising the BRICS group. Each of the five BRICS countries has recorded the highest TB incidence rate among the territories of the corresponding WHO region. The Omsk region is a large industrial region in Russia located in the southern part of West Siberia. The territory covers 141,000 square kilometres, with a population of over 1,970,000 people. Complex programmes for TB prevention have led to significant progress toward making the situation stable and decreasing morbidity and mortality rates. The current problem is the spread of TB drug-resistant forms and TB incidence among HIV-infected patients 3 . During 2010 to 2014, TB incidence in the Omsk region decreased by 30 per cent from 115.2 to 86.1 per 100,000 population per year. However, the incidence of TB combined with HIV increased four-fold from 2.4 to 9.7 per 100,000 people per year 4 , and the incidence of MDR TB increased two-fold from 3.5 to 7.6 per 100,000 people 3 . The results of recent studies have demonstrated that the Beijing genotype is actively circulating in most Russian regions, including Siberia. This genotype is defined by high transmissibility and virulence and is associated with multidrug resistance 5, 6 . The information about the Mycobacterium tuberculosis genotypes circulating in the Omsk region is lacking. The purpose of this study was to investigate the genetic characteristics of M. tuberculosis isolates found in the southern part of West Siberia in the Omsk region.
Material & Methods
Sputum samples were collected during March 2013 to January 2015 from all those patients with pulmonary TB who lived in the Omsk region and were admitted to Clinical TB Dispensary at Omsk, Russia. The age range of the patients was 19-78 years. The inclusion criteria were pulmonary TB, residency in the Omsk region, being treated in TB hospitals, age over 18, and consent to participate in the study. The exclusion criteria were as follows: (i) age less than 18 yr, (ii) extrapulmonary TB, (iii) absence of bacterial excretion, and (iv) patient refused to participate in the study. 
Bacterial culture and antibiotic susceptibility testing:
The cultivation of M. tuberculosis and the testing of drug susceptibility of isolates to 10 primary and secondary anti-TB drugs were carried out over four weeks using the method of absolute concentrations 5 in Lowenstein-Jensen (L-J) medium (Merck, USA).
DNA extraction: DNA samples were extracted from pure cultures of M. tuberculosis. The inactivated culture was centrifuged for three min at 3000×g, then the supernatant was removed and 500 μl of solution 1 (2 mM borate buffer pH 9.5, 1% 2-methoxyethanol) was added to the residue, vortexed and heated for 10 min at 95°C. This was centrifuged for another three minutes at 3000×g, and then, the supernatant containing the DNA was transferred to a clean tube and used as a template for the polymerase chain reaction (PCR) 7 .
Fifteen loci mycobacterial interspersed repetitive units (MIRU)-VNTR typing:
MIRU-VNTR typing by amplifying 15 loci (MIRU2, MIRU4, MIRU10, MIRU16, MIRU20, MIRU23, MIRU24, MIRU26, MIRU27, MIRU31, MIRU39, MIRU40, ETRA, ETRB and ETRC) was performed as previously described with some modifications 5, 8 . The oligonucleotide primer sequences are given in Table  I . For each reaction, DNA from M. tuberculosis H37Rv was used as a positive control, and sterile water was used as a negative control. PCR products were electrophoretically separated on 6 per cent polyacrylamide gel, using a 100 bp DNA ladder as a size marker. The database 'MIRU-VNTRplus' (http:// miru-vntrplus.org) was used to determine the genetic lineage of each isolate 9 .
Identification of mutations associated with the development of resistance to isoniazid (INH) and rifampicin (RIF):
The identification of mutations of katG315 and rpoB531 was performed as previously described using PCR-restriction fragment length polymorphism (RFLP) analysis 10 . Primers were designed for the amplification of fragments containing katG315 (MSPA and MSPB) and rpoB531 (MUT531U and MUT531R) ( Table I) .
Statistical analysis:
The data were analysed using STATISTICA 6.0 (StatSoft Inc., USA). MIRU-VNTRplus resource (http://www.miru-vntrplus.
org/MIRU/index.faces) was used for building an Unweighted Pair Group Method with Arithmetic
Mean dendrogram of MIRU-VNTR digital profiles treated as categorical variables. The Hunter-Gaston Discrimination Index (HGDI) was used as an estimate of the allelic diversity for each genotype in the 15 combined loci 11 , and was calculated 12 using the 'Discriminatory power calculator' (http://insilico.ehu.eus/).
Results
One hundred clinical isolates taken from patients (85 men and 15 women) with pulmonary TB were included in the study. The ratio of men to women was 5.66:1 (85 vs. 15%), the mean age of patients was 35.6±2.37 years. Fifty patients were HIV-positive. The clinical TB forms were infiltrative (70.0%), disseminated (13.0%) and fibrous-cavernous (12.0%) TB. Primary TB was detected in 82 patients; the others had a chronic form of TB with reinfection and reactivation. (Figure) were found among the 100 isolates. Twenty six isolates (26%) were unique, and the remaining 74 were grouped into 10 clusters. HGDI was 0.888 and the clustering index was 74.0 per cent. Seventy two isolates belonged to the Beijing family and 61 (85.0%) were grouped into five clusters each containing 2 to 23 isolates. Two major clusters contained 23 isolates and had an allelic profile of 223325173533424 and 223325193533424, respectively.
VNTR typing: Thirty six different VNTR genotypes
Other genetic families were also detected: LAM (Latin American Mediterranean) in 11 isolates (11.0%), Haarlem (4.0%) and S family (2.0%).
The genetic family of 11 isolates could not be determined (labelled as unknown). Six VNTR profiles were found in these non-classified isolates. Four of these isolates were unique, and the remaining seven were grouped into three clusters. Allelic polymorphism analysis of each MIRU-VNTR locus demonstrated variability in the number of tandem repeats (Table II) . The number of alleles detected per locus ranged from one to nine. MIRU16, MIRU26, MIRU31 loci showed the highest level of polymorphism in the unclassified isolates. Among the Beijing isolates, MIRU26 (HGDI=0.548) was the most polymorphic locus, while six loci were monomorphic, having the same allelic profile (MIRU02, MIRU04, MIRU16, MIRU23, MIRU24 and ETRB). The HDGI of the rest of the loci ranged from 0.027 to 0.27. In the non-Beijing isolates (n=17), the MIRU02, MIRU10, MIRU40, ETRA and ETRC loci were polymorphic (Table II) .
Only 16 per cent of isolates were susceptible to anti-TB drugs ( Table III) . The rest were resistant to the first-line drugs in different combinations, such as INH (83%), RIF (77%), streptomycin (72%) and ethambutol (13%), and to the second-line drugs, including ethionamide (30%), ofloxacin (21%), kanamycin (12%), capreomycin (9%), para-aminosalicylic acid (8%) and cycloserine (2%).
Seventy seven per cent of multiple drug-resistant TB isolates were resistant to at least INH and RIF. Of these, 12 (15.6%) were resistant to all first-line drugs, including streptomycin and ethambutol.
Of the 77 drug-resistant isolates, 59 (76.6%) belonged to the Beijing genotype and 18 to other genetic families. The level of multidrug resistance among Beijing and non-Beijing genotypes did not differ significantly.
Discussion
Epidemiological studies are essential in TB surveillance, along with effective monitoring and preventive measures 13 . Understanding the distribution of the various M. tuberculosis genotypes allows the impact of genetic polymorphism on the course of the disease deciphered, the epidemiologically significant genotypes to be identified, the infection history to be deduced and its development to be predicted 14 . 15, 16 . The Beijing genotype was recorded in 20.3 per cent cases in the north India (Varanasi) 13 . The Beijing genotype has major epidemiological and clinical value in Russia. The prevalence of the Beijing genotype ranged from 27.0 to 66.8 per cent of cases in different regions of Western and Eastern Siberia (Novosibirsk region, Republic of Buryatia, Tomsk region) 10, 14, 17 .
The LAM family was represented by 11 isolates with different allelic profiles. In terms of frequency of occurrence LAM ranks in second place in most regions of Russia (12 to 16%) 10, [18] [19] [20] . The LAM prevalence rate in all studied regions within Russia and the former Soviet Union amounted to 29. 4 22, 23 . Based on phylogeographic analysis of the global dataset and robust molecular markers, Mokrousov et al 22 suggested that LAM family originated in the Western Mediterranean region although its dating remains unknown and its dispersal was determined by large-scale human migrations flaws.
The S family isolates occurred in 2 per cent of cases; in the Novosibirsk region the prevalence of this family was 7 per cent, but it reached 90 per cent in Yakutia among the indigenous people, where it was suggested to be endemic 10, 24 . S family is one of the M. tuberculosis genetic families named so because first identified in Sicily and later in Sardinia 25, 26 .
The Haarlem family was found in 4 per cent of cases, while in South America this family was predominant among drug-resistant M. tuberculosis (43.6%) 27 .
The MDR subsample in this study included 93.5 per cent isolates with katG315 mutation and 90 per cent of isolates with rpoB531 mutation. The predominance of these major mutations had previously been shown in the Novosibirsk oblast 5, 10 . Under the influence of selective pressure their accumulation takes place, and phenotypically, there is an increase of the proportion of MDR strains in the population of M. tuberculosis. The presence of insignificant number of mutational events indicates that these are an epidemic type of M. tuberculosis that is actively spreading in the Omsk region. Such isolates can be epidemiologically linked to recent contamination from the public infection reservoir, despite the lack of direct contact with isolated foci 11, 24 . Considerable clustering and the presence of two large clusters belonging to the Beijing family with numerous branches in the dendrogram defined the dissemination and active circulation of this genotype in the Omsk region. Perhaps, the lack of a clear epidemiological link between patients in clusters confirms the active dissemination of drug-resistant M. tuberculosis isolates among the population in the Omsk region.
This study had some limitations. One is the high proportion of M. tuberculosis drug-resistant isolates compared with population-based studies. Further, we were not able to use 15-loci MIRU-VNTR typing to determine the genetic family of 11 isolates. This can be attributed to the lack of a sufficient number of MIRU loci and the appearance of new genetic variants of M. tuberculosis in the Omsk region.
Larger studies with representative sampling need to elucidate the actual status and role of these genotypes in the dissemination and transmission of TB in the southern part of West Siberia. This is a baseline study of the M. tuberculosis population structure in Omsk region, and may serve as an impetus for future molecular epidemiological studies in the southern part of West Siberia, and will help to estimate genetic diversity of the global tubercle bacilli.
In conclusion, the use of 15-locus VNTR typing revealed the circulation of different genetic families, including Beijing, LAM, S and Haarlem. The predominance of Beijing genotype was found among isolates with multidrug resistance. The most common mutations among the MDR isolates were katG315 and rpoB531. The data obtained are crucial for the selection and evaluation of the effective preventive measures to reduce the spread of MDR strains in the Omsk region.
